Antibody · IBD (크론·대장)

38개 · ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-6 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved38 programs
AntibodyCurated CoreFDAAbbVieApproved

adalimumab (Humira, Hyrimoz, Amjevita)

Rheumatoid arthritis, psoriasis, Crohn's disease, ulcerative colitis, axial SpA · TNF-α

#TNF-#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 574Status Approved
AntibodyCurated CoreFDAJohnson & JohnsonApproved

ustekinumab (Stelara, Wezlana)

Psoriasis, psoriatic arthritis, Crohn's disease, ulcerative colitis · IL-12 / IL-23 (p40)

#IL-12IL-23p40#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 195Status Approved
AntibodyCurated CoreFDAAbbVieApproved

risankizumab-rzaa (Skyrizi, BI 655066, risankizumab)

Plaque psoriasis, PsA, Crohn's disease, ulcerative colitis · IL-23 p19

#IL-23p19#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 110Status Approved
AntibodyCurated CoreFDAJohnson & JohnsonApproved

guselkumab (Tremfya, CNTO 1959)

Plaque psoriasis, psoriatic arthritis, ulcerative colitis, Crohn's disease · IL-23 p19

#IL-23p19#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 87Status Approved
AntibodyCurated CoreJanssenApproved

Remicade® (Remicade®)

Crohn's Disease · Ankylosing Spondylitis

#AnkylosingSpondylitis#Antibody#Approved#BioJungboMoa-pick#Popular+3
Trials 406Status Active
AntibodyCurated CorestaleTakedaPhase 2

Vedolizumab (Vedolizumab)

Ulcerative Colitis and Crohn's Disease · Colitis

#Colitis#Antibody#Phase2#BioJungboMoa-pick#Popular+4
Trials 90Status Active
AntibodyCurated CorestaleMario Negri Institute for Pharm…Approved

Certolizumab pegol (Certolizumab pegol)

Rheumatoid Arthritis · Crohn's Disease

#CrohnsDisease#Antibody#Approved#BioJungboMoa-pick#Popular+3
Trials 60Status Active
AntibodyLimited DatastaleUCB PharmaPhase 3

CDP870 (Certolizumab Pegol, Certolizumab Pegol (CDP870))

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Phase3#Popular#monoclonal-antibody+1
Trials 57Status Active
AntibodyLimited DatastaleNantes University HospitalPreclinical

Azathioprine + infliximab (Azathioprine + infliximab)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Preclinical#monoclonal-antibody#NKcellsaswellastheirrecentdegran+1
Trials 30Status Recruiting
AntibodyLimited DatastaleJanssenPreclinical

Anti TNF therapy including infliximab (Anti TNF therapy including infliximab)

Crohn's Disease; Ulcerative Colitis · Crohn's Disease

#CrohnsDisease#Antibody#Preclinical#monoclonal-antibody#UlcerativeColitis+2
Trials 22Status Recruiting
AntibodyLimited DatastaleAbbViePhase 2

Lutikizumab (Lutikizumab)

Ulcerative Colitis · Hidradenitis Suppurativa

#HidradenitisSuppurativa#Antibody#Phase2#monoclonal-antibody#UlcerativeColitis+2
Trials 12Status Recruiting
AntibodyLimited DatastaleUniversity of CalgaryApproved

ustekinumab (Stelara, Anti-IL12/23 or anti-IL23 - Ustekinumab)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Approved#monoclonal-antibody#University
Trials 4Status Recruiting
AntibodyLimited DatastaleBiogenPhase 2

Natalizumab (Natalizumab)

Crohn's Disease · Multiple Sclerosis, Relapsing-Remitting

#MultipleSclerosisRelapsing-Remit#Antibody#Phase2#monoclonal-antibody#CrohnsDisease+1
Trials 4Status Active
AntibodyLimited DatastaleUniversity of CalgaryApproved

Anti-IL12/23 or anti-IL23 - Risankizumab (Anti-IL12/23 or anti-IL23 - Risankizumab)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Approved#monoclonal-antibody#University
Trials 3Status Recruiting
AntibodyLimited DatastaleHoffmann-La RochePhase 3

Etrolizumab (Etrolizumab)

Ulcerative Colitis · Ulcerative Colitis

#UlcerativeColitis#Antibody#Phase3#monoclonal-antibody#Hoffmann-La
Trials 3Status Active
AntibodyLimited DatastaleJanssenApproved

ustekinumab (Stelara, 1: filgotinib 2: ustekinumab 3: vedolizumab 4: infliximab))

Ulcerative Colitis (UC) · Ulcerative Colitis (UC)

#UlcerativeColitisUC#Antibody#Approved#monoclonal-antibody#Janssen
Trials 1Status Recruiting
AntibodyLimited DatastaleJanssenApproved

ustekinumab (Stelara, 1: infliximab 2: filgotinib 3: ustekinumab 4: vedolizumab)

Ulcerative Colitis (UC) · Ulcerative Colitis (UC)

#UlcerativeColitisUC#Antibody#Approved#monoclonal-antibody#Janssen
Trials 1Status Recruiting
AntibodyLimited DatastaleJanssenApproved

ustekinumab (Stelara, 1: ustekinumab 2: vedolizumab 3: infliximab 4: filgotinib)

Ulcerative Colitis (UC) · Ulcerative Colitis (UC)

#UlcerativeColitisUC#Antibody#Approved#monoclonal-antibody#Janssen
Trials 1Status Recruiting
AntibodyLimited DatastaleJanssenApproved

ustekinumab (Stelara, 1: vedolizumab 2: infliximab 3: filgotinib 4: ustekinumab)

Ulcerative Colitis (UC) · Ulcerative Colitis (UC)

#UlcerativeColitisUC#Antibody#Approved#monoclonal-antibody#Janssen
Trials 1Status Recruiting
AntibodyLimited DatastaleAbbViePreclinical

Alvotech Biosimilar to Adalimumab (AVT02, AVT02 (Alvotech Biosimilar to Adalimumab))

Crohn Disease; Ulcerative Colitis · Crohn Disease

#CrohnDisease#Antibody#Preclinical#monoclonal-antibody#UlcerativeColitis+1
Trials 1Status Active

1 / 2 pages

← PreviousNext →